BVF as of March 31, 2020
Portfolio Holdings for BVF
BVF holds 57 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Principia Biopharma | 8.8 | $94M | 1.6M | 59.38 | |
| Ionis Pharmaceuticals (IONS) | 8.6 | $92M | 1.9M | 47.28 | |
| Ac Immune Sa (ACIU) | 7.3 | $78M | 11M | 6.91 | |
| Springworks Therapeutics (SWTX) | 7.0 | $75M | 2.8M | 27.00 | |
| Xoma Corp Del (XOMA) | 5.3 | $56M | 2.8M | 20.35 | |
| Xencor (XNCR) | 4.7 | $51M | 1.7M | 29.88 | |
| Cytokinetics (CYTK) | 4.3 | $46M | 3.9M | 11.79 | |
| Merus N V (MRUS) | 4.0 | $43M | 3.5M | 12.10 | |
| Calithera Biosciences | 4.0 | $42M | 9.6M | 4.44 | |
| Molecular Templates | 3.5 | $38M | 2.9M | 13.29 | |
| Revolution Medicines (RVMD) | 2.9 | $31M | 1.4M | 21.91 | |
| Xenon Pharmaceuticals (XENE) | 2.8 | $30M | 2.7M | 11.34 | |
| Cytomx Therapeutics (CTMX) | 2.8 | $30M | 3.9M | 7.67 | |
| Kura Oncology (KURA) | 2.3 | $24M | 2.4M | 9.95 | |
| Anaptysbio Inc Common (ANAB) | 2.2 | $24M | 1.7M | 14.13 | |
| Syndax Pharmaceuticals (SNDX) | 2.2 | $24M | 2.1M | 10.97 | |
| Replimune Group (REPL) | 1.8 | $20M | 2.0M | 9.97 | |
| Five Prime Therapeutics | 1.6 | $18M | 7.8M | 2.27 | |
| Phathom Pharmaceuticals (PHAT) | 1.6 | $18M | 677k | 25.82 | |
| Glycomimetics | 1.6 | $17M | 7.4M | 2.28 | |
| Verastem | 1.6 | $17M | 6.3M | 2.64 | |
| Immunovant (IMVT) | 1.5 | $16M | 1000k | 15.57 | |
| Infinity Pharmaceuticals (INFIQ) | 1.4 | $15M | 17M | 0.84 | |
| Mersana Therapeutics | 1.3 | $14M | 2.4M | 5.83 | |
| Pieris Pharmaceuticals | 1.2 | $13M | 5.9M | 2.28 | |
| X4 Pharmaceuticals | 1.1 | $12M | 1.2M | 10.00 | |
| Essa Pharma (EPIX) | 0.9 | $9.7M | 2.4M | 4.00 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.9 | $9.5M | 3.8M | 2.48 | |
| Black Diamond Therapeutics (BDTX) | 0.9 | $9.5M | 379k | 24.95 | |
| Selecta Biosciences | 0.8 | $8.7M | 3.6M | 2.41 | |
| Mei Pharma | 0.8 | $8.1M | 5.0M | 1.61 | |
| Kezar Life Sciences | 0.6 | $6.8M | 1.6M | 4.36 | |
| Cti Biopharma | 0.6 | $6.4M | 6.9M | 0.92 | |
| Galmed Pharmaceuticals | 0.6 | $6.3M | 1.8M | 3.46 | |
| Akero Therapeutics (AKRO) | 0.6 | $6.0M | 283k | 21.20 | |
| Forward Pharma A/s Sponsord Ads | 0.5 | $5.4M | 926k | 5.81 | |
| Ideaya Biosciences (IDYA) | 0.5 | $5.3M | 1.3M | 4.12 | |
| Prevail Therapeutics Ord | 0.5 | $5.3M | 432k | 12.19 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $4.9M | 692k | 7.06 | |
| Sutro Biopharma (STRO) | 0.5 | $4.9M | 476k | 10.20 | |
| Spero Therapeutics (SPRO) | 0.4 | $4.6M | 563k | 8.08 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $4.6M | 2.2M | 2.11 | |
| Ovid Therapeutics (OVID) | 0.4 | $3.8M | 1.3M | 2.98 | |
| Genocea Biosciences (GNCAQ) | 0.3 | $3.6M | 2.1M | 1.72 | |
| Erytech Pharma Sa | 0.3 | $3.3M | 625k | 5.34 | |
| Argenx Se (ARGX) | 0.3 | $3.3M | 25k | 131.72 | |
| Alpine Immune Sciences | 0.3 | $3.3M | 1.1M | 2.88 | |
| Gamida Cell | 0.3 | $3.0M | 1.0M | 3.02 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $2.6M | 6.2M | 0.41 | |
| Biolinerx | 0.2 | $2.3M | 1.7M | 1.33 | |
| Surface Oncology | 0.2 | $1.8M | 983k | 1.87 | |
| Galapagos Nv- (GLPG) | 0.1 | $1.5M | 7.7k | 195.86 | |
| Spring Bk Pharmaceuticals In | 0.1 | $885k | 952k | 0.93 | |
| Regulus Therapeutics | 0.1 | $734k | 1.6M | 0.46 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $535k | 39k | 13.87 | |
| Eiger Biopharmaceuticals | 0.0 | $463k | 68k | 6.80 | |
| Novus Therapeutics | 0.0 | $267k | 685k | 0.39 |
